These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11741485)

  • 1. Diaminoindanes as microsomal triglyceride transfer protein inhibitors.
    Ksander GM; deJesus R; Yuan A; Fink C; Moskal M; Carlson E; Kukkola P; Bilci N; Wallace E; Neubert A; Feldman D; Mogelesky T; Poirier K; Jeune M; Steele R; Wasvery J; Stephan Z; Cahill E; Webb R; Navarrete A; Lee W; Gibson J; Alexander N; Sharif H; Hospattankar A
    J Med Chem; 2001 Dec; 44(26):4677-87. PubMed ID: 11741485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER.
    Liao W; Hui TY; Young SG; Davis RA
    J Lipid Res; 2003 May; 44(5):978-85. PubMed ID: 12588952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.
    Chandler CE; Wilder DE; Pettini JL; Savoy YE; Petras SF; Chang G; Vincent J; Harwood HJ
    J Lipid Res; 2003 Oct; 44(10):1887-901. PubMed ID: 12837854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, SLx-4090: biochemical, pharmacodynamic, pharmacokinetic, and safety profile.
    Kim E; Campbell S; Schueller O; Wong E; Cole B; Kuo J; Ellis J; Ferkany J; Sweetnam P
    J Pharmacol Exp Ther; 2011 Jun; 337(3):775-85. PubMed ID: 21406547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors.
    Robl JA; Sulsky R; Sun CQ; Simpkins LM; Wang T; Dickson JK; Chen Y; Magnin DR; Taunk P; Slusarchyk WA; Biller SA; Lan SJ; Connolly F; Kunselman LK; Sabrah T; Jamil H; Gordon D; Harrity TW; Wetterau JR
    J Med Chem; 2001 Mar; 44(6):851-6. PubMed ID: 11300866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.
    Mera Y; Odani N; Kawai T; Hata T; Suzuki M; Hagiwara A; Katsushima T; Kakutani M
    J Pharmacol Exp Ther; 2011 Feb; 336(2):321-7. PubMed ID: 20974698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.
    Robinson RP; Bartlett JA; Bertinato P; Bessire AJ; Cosgrove J; Foley PM; Manion TB; Minich ML; Ramos B; Reese MR; Schmahai TJ; Swick AG; Tess DA; Vaz A; Wolford A
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4150-4. PubMed ID: 21684740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
    Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells.
    Jamil H; Gordon DA; Eustice DC; Brooks CM; Dickson JK; Chen Y; Ricci B; Chu CH; Harrity TW; Ciosek CP; Biller SA; Gregg RE; Wetterau JR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11991-5. PubMed ID: 8876250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein.
    Luo Y; Shelly L; Sand T; Chang G; Jiang XC
    J Pharmacol Exp Ther; 2010 Dec; 335(3):653-8. PubMed ID: 20805304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J; Kazemian P; Kulinski A; Rudy D; Aiton A; Thibert RJ; Adeli K
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1035-47. PubMed ID: 11027587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist.
    Bakillah A; Nayak N; Saxena U; Medford RM; Hussain MM
    Biochemistry; 2000 Apr; 39(16):4892-9. PubMed ID: 10769147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.
    Lettéron P; Sutton A; Mansouri A; Fromenty B; Pessayre D
    Hepatology; 2003 Jul; 38(1):133-40. PubMed ID: 12829995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine.
    Lin MC; Wang EJ; Lee C; Chin KT; Liu D; Chiu JF; Kung HF
    J Nutr; 2002 Jun; 132(6):1165-8. PubMed ID: 12042427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents.
    Magnin DR; Biller SA; Wetterau J; Robl JA; Dickson JK; Taunk P; Harrity TW; Lawrence RM; Sun CQ; Wang T; Logan J; Fryszman O; Connolly F; Jolibois K; Kunselman L
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1337-40. PubMed ID: 12657277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide releasing morpholine derivatives as hypolipidemic and antioxidant agents.
    Chrysselis MC; Rekka EA; Siskou IC; Kourounakis PN
    J Med Chem; 2002 Nov; 45(24):5406-9. PubMed ID: 12431068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly.
    Gordon DA; Jamil H
    Biochim Biophys Acta; 2000 Jun; 1486(1):72-83. PubMed ID: 10856714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits.
    Wetterau JR; Gregg RE; Harrity TW; Arbeeny C; Cap M; Connolly F; Chu CH; George RJ; Gordon DA; Jamil H; Jolibois KG; Kunselman LK; Lan SJ; Maccagnan TJ; Ricci B; Yan M; Young D; Chen Y; Fryszman OM; Logan JV; Musial CL; Poss MA; Robl JA; Simpkins LM; Slusarchyk WA; Sulsky R; Taunk P; Magnin DR; Tino JA; Lawrence RM; Dickson JK; Biller SA
    Science; 1998 Oct; 282(5389):751-4. PubMed ID: 9784135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal 1000 residues of apolipoprotein B associate with microsomal triglyceride transfer protein to create a lipid transfer pocket required for lipoprotein assembly.
    Dashti N; Gandhi M; Liu X; Lin X; Segrest JP
    Biochemistry; 2002 Jun; 41(22):6978-87. PubMed ID: 12033930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.